The prognosis of patients with familial hypercholesterolemia is worse than those without this disease at any level of untreated low-density lipoprotein cholesterol. Patients with acute coronary syndrome and a history of heterozygous familial hypercholesterolemia treated with high dose statins have three times the highest risk of death and nonfatal myocardial infarction within one year when compared to matched individuals without familial hypercholesterolemia.